A recent study examined the possible effects of more access to cannabis on workplace injuries in younger workers.
In a recently published research letter, researchers from the University of Wisconsin-Parkside, San Diego State University, and Bentley University, examined how recreational cannabis laws affected workplace injuries, specifically for workers between the ages of 20 and 34 (1). They hypothesized that cannabis laws and use could be associated with more workplace injuries by decreasing cognition from increased cannabis use, or could be associated with fewer injuries if cannabis is being used to treat pain or as a substitute for other substances (1). The study, “Recreational Marijuana Legalization and Workplace Injuries Among Younger Workers,” was published in JAMA Health Forum on February 23, 2024 (1).
As noted in the study's introduction, states in the US are increasingly loosening cannabis restrictions: 24 states and Washington DC have made the sale and possession of certain amounts of cannabis legal as of 2012 (1). More research is needed on how this has affected workplace health and safety, the researchers stated (1).
Researchers used data from the Bureau of Labor Statistics Survey of Occupational Injuries and Illnesses to examine state-by-year data on workplace injury using an analysis sample of 632 state-year observations (1). They also adjusted for “dummy variables for each state and year, presence of a medical marijuana law, presence of a marijuana decriminalization or depenalization law, macroeconomic conditions, demographic characteristics, substance use policies, tobacco policies, per capita COVID-19 deaths, and the maximum workers compensation benefit,” (1).
The researchers concluded that a part of their hypothesis had been consistent with the results. “In this study, RMLs [recreational marijuana laws] that allow recreational marijuana sales were associated with a 10% increase in workplace injuries among individuals aged 20 to 34 years,” the researchers stated in the discussion section (1). In comparison, based on the decreased receiving of workers’ compensation benefits and of certain injuries, older workers may have benefitted from access to cannabis, the researchers suggested (1).
More research will be needed for analyzing the long-term effects of cannabis on workplace injuries, the researchers also noted (1).
For a deep dive into the complicated world of cannabis workplace health and safety, read more in “Cultivators Address New Health and Safety Issues for Plants and Workers” from our Tech Innovations column.
Also check out recent coverage of California’s new laws regarding cannabis use outside the workplace.
Reference
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.